Amgen 8-K

Summary

Material cybersecurity incident involving unauthorized activity in third-party cloud environments. Amgen identified in July 2026 that data—including proprietary information and patient protected health information—had been exfiltrated. As of 7/29/2026, it deemed the incident material because of the apparent volume of files and potential sensitivity of their contents. Amgen has identified no impact to products, manufacturing, financial reporting systems, or its ability to meet patient needs, and believes the incident is not reasonably likely to materially affect its financial condition or results of operations.

Investor Takeaways

• The investigation continues; watch for findings on the information accessed or exfiltrated and any resulting impact.
• Amgen is evaluating legal and regulatory notification requirements and says it will notify impacted patients as required by its findings.